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the city of Ulm (8). In Cologne, about 
two thirds of the bank voles captured 
at the exposure site carried PUUV and 
are assumed to be the most probable 
source of infection. Increased sight-
ings of rodents were reported by local 
health ofﬁ  ces and pest control units. 
Studies at putative exposure sites in 
southeastern Germany in 2004 also 
showed a high prevalence of PUUV in 
the respective bank vole populations.
These cases are also the ﬁ  rst in-
dication, to our knowledge, that rec-
reational activities in a forested city 
park, infested by hantavirus-infected 
rodents, may lead to human infections. 
This possibility should be investigated 
carefully in outbreak situations and 
may have practical implications for 
the future surveillance and prevention 
of NE in Europe.
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Effect of Hurricane 
Katrina on 
Arboviral Disease 
Transmission
 To the Editor: Rarely has the 
aftermath of a natural disaster in the 
continental United States resulted in 
increased transmission of mosquito-
borne viruses (1). However, on August 
29, 2005, Hurricane Katrina struck 
Louisiana and Mississippi, where 
mosquito-borne West Nile (WNV) 
and St. Louis encephalitis viruses are 
endemic. 
Using data from the ArboNET 
system of the Centers for Disease 
Control and Prevention, we evaluated 
the short-term effects of Hurricane Ka-
trina on the reported incidence of hu-
man West Nile neuroinvasive disease 
(WNND) and Saint Louis encephalitis 
(SLE) in Louisiana and Mississippi us-
ing the reported week of onset and the 
year (2003–2005). We also evaluated 
incidence by onset date and county (or 
parish) over 3 time intervals (January 
1–August 31, September 1–Septem-
ber 30, and October 1–October 30) in 
2005. Reporting lag was evaluated by 
onset dates and corresponding dates of 
reports. Because the completeness of 
reporting of West Nile fever and other 
arboviral fever cases is highly vari-
able, only reports of human WNND 
and SLE were considered.
In Louisiana, the highest reported 
incidence of WNND occurred in the 
second week of August 2005, before 
Hurricane Katrina made landfall. Al-LETTERS
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though the number of cases reported 
in 2005 (117) was higher than in 2003 
(85) or 2004 (101), the number of 
cases peaked during roughly the same 
weeks in each year. In Mississippi, the 
total number of cases reported in 2005 
(39) was only slightly higher than in 
previous years (31 in 2004 and 34 in 
2003). The number of cases peaked 
in mid-September 2005, later than the 
peak in 2004, but similar to when a 
second peak occurred in 2003. Thus, 
the increase in WNND incidence for 
either state does not appear to be hur-
ricane-related.  
In Louisiana, 82 WNND cases in 
20 parishes had onset between January 
1, 2005 and August 31, 2005. In com-
parison, 25 WNND cases had onset 
between September 1, 2005 and Sep-
tember 30, 2005; a total of 14 of these 
cases in 7 parishes had not reported 
WNND cases previously in 2005; a 
total of 5 of these parishes had de-
tected WNV activity in animals before 
the hurricane. From October 1, 2005 
to October 31, 2005, a total of 10 ad-
ditional WNND cases were reported 
in Louisiana, including 1 case from a 
parish that had not previously reported 
cases. Only 5 cases with illness onset 
after the hurricane resided in coastal 
parishes. In Mississippi, 17 WNND 
cases in 10 counties had onset be-
tween January 1, 2005 and August 31, 
2005. Twenty cases had onset between 
September 1, 2005 and September 30, 
2005, including 9 cases in 4 counties 
that had not reported WNND cases 
previously in 2005; a total of 2 of these 
counties had detected WNV activity 
in animals before the hurricane. From 
October 1, 2005 to October 31, 2005 
2 more WNND cases were reported in 
Mississippi, including 1 from a county 
that had not reported cases previously. 
All cases with illness onset after the 
hurricane resided in inland counties. 
Thus, in both states the coastal coun-
ties and parishes that were hardest hit 
by the hurricane had the fewest num-
ber of posthurricane WNND cases.
 In 2005, Louisiana reported 2 
SLE cases and Mississippi reported 
5. Both Louisiana cases and 4 of the 
Mississippi cases had onset of illness 
after September 1. In 2004, no SLE 
cases had been reported by either of 
these states. In 2003, a total of 9 cases 
were reported in Louisiana (3 with on-
set in September) and 2 in Mississippi 
(with onsets in May and June). Thus, 
Hurricane Katrina did not appear to 
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increase SLE incidence in Louisiana, 
and if it did increase incidence in Mis-
sissippi, the increase was minimal.
In both 2003 and 2004, Louisi-
ana’s median reporting time to Ar-
boNET was ≈30 days. In 2005, the 
median reporting time prehurricane 
was 36 days and posthurricane was 69 
days. Louisiana state ofﬁ  cials believed 
that this reporting lag was largely due 
to impaired transport and collection 
of biologic samples and relocation 
of diagnostic facilities immediately 
following the hurricane. In contrast, 
in 2003 and 2004, Mississippi’s me-
dian reporting time to ArboNET was 
21 days and 36 days, respectively. In 
2005, the median reporting time pre-
hurricane was 23 days and posthur-
ricane was 14 days. Mississippi state 
ofﬁ   cials believed that the improved 
reporting time was due to the addi-
tional help and longer hours worked 
by health department ofﬁ  cials follow-
ing the hurricane. 
Although Hurricane Katrina dis-
rupted WNV surveillance in Louisi-
ana, it did not appear to increase the 
incidence of WNND and SLE in either 
Louisiana or Mississippi. In coastal 
areas, the hurricane destroyed hous-
ing and impeded vector control, thus 
possibly increasing the risk of mos-
quito-borne infections (1,2). However, 
hurricane-force winds and heavy ﬂ  ood-
ing might have actually decreased the 
risk of WNV and SLE transmission 
by dispersing or killing birds and mos-
quitoes, and destroying their habitat. 
Many people were promptly evacuated 
to less affected areas, where, on the ba-
sis of previous years’ data showing sea-
sonality of WNV transmission, the risk 
of infection was probably decreasing. 
Natural disasters do not usually cause 
an immediate increase in arboviral 
diseases (1,2). However, if hurricanes 
strike early in transmission season, 
there could be a late increase in risk 
after vector and host populations are 
re-established. In addition, risk could 
increase when people are relocated to 
areas where transmission is intense. 
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Threat to Ceﬁ  xime 
Treatment for 
Gonorrhea 
To the Editor: From November 
2002 through May 2003, a total of 4 
Japanese men, ranging in age from 23 
to 45 years, visited the Department of 
Urology at Toyota Memorial Hospital, 
Toyota, Japan. Physical examinations 
showed urethral discharge and dysuria. 
Each had had sexual contact with sex 
workers in central Japan. Four strains 
of Neisseria gonorrhoeae were isolat-
ed from urethral specimens. Treatment 
comprised 200 mg ceﬁ  xime, twice a 
day for 3 days. However, all 4 patients 
returned to the clinic with continuing 
symptoms, despite having completed 
the prescribed course of ceﬁ  xime and 
abstaining from sexual activity. N. 
gonorrhoeae was again isolated from 
urethral swabs. Each patient was then 
treated with 1 g intravenous ceftriax-
one. In the 3 patients who returned to 
the clinic for followup, the ceftriaxone 
treatment resulted in clinical and mi-
crobiologic cure.
Pulsed-ﬁ   eld gel electrophoresis 
(PFGE) analysis of the SpeI-digested 
DNAs of N. gonorrhoeae was per-
formed to assess the relatedness of 
pre- and posttreatment isolates (1). 
For these 8 isolates, MICs of penicil-
lin G, tetracycline, ceﬁ  xime, cefdinir, 
cefodizime, ceftriaxone, levoﬂ  oxacin, 
azithromycin, and spectinomycin were 
determined on chocolate agar (GC) 
medium base supplemented with 1% 
IsoVital X (Becton Dickinson, Frank-
lin Lakes, NJ, USA) and containing 
serial 2-fold dilutions of each agent 
(2). Media were inoculated with 104 
CFU and incubated at 35°C in 5% CO2 
overnight. The MIC was deﬁ  ned as the 
lowest concentration inhibiting growth 
to <1 CFU. β-lactamase activity of 
the isolates was tested with a nitroce-
ﬁ  n disk. The nucleotide sequences of 
the full-length penA gene encoding 
the penicillin-binding protein 2 (PBP 
2) were identiﬁ  ed in the isolates (1). 
Brieﬂ   y, genomic DNAs from each 
isolate were subjected to PCR to am-
plify 3 fragments of the penA gene of 
N. gonorrrhoeae. PCR products were 
sequenced by the dye terminator meth-
od and with an automatic sequencer.
In each of the 4 cases, the PFGE 
patterns of the pre- and posttreatment 
isolates had the same numbers of 
bands (12–16 fragments), and the cor-
responding bands were the same ap-
parent size; the pre- and posttreatment 
isolates were indistinguishable (3). 
MICs of antimicrobial agents for the 
8 isolates are shown in the Table. All 
isolates were enzymatically negative 
for β-lactamase and possessed identi-
cal mosaic alterations in PBP 2. The 
mosaic PBP 2 was composed of frag-
ments of PBP 2 from N. cinerea and 
N. perﬂ  ava and was identical to that 
identiﬁ  ed in our previous study (1).
Until recently, Japanese guide-
lines recommended oral administra-
tion of ceﬁ  xime, 200 mg twice a day 